U.S., Nov. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07252440) titled 'A Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease' on Nov. 14.
Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled parallel Phase II core period study to evaluate the efficacy and safety of TTYP01 Tablets in early symptomatic AD (Mild cognitive impairment [MCI] due to AD, or mild AD dementia).
A total of 180 participants will be randomized into 3 parallel groups: 2 TTYP01 dose groups and 1 placebo group.
Study Start Date: Dec. 05
Study Type: INTERVENTIONAL
Condition:
AD
Early Alzheimer's Disease
Intervention:
DRUG: TTYP01 tables 60mg
2 TTYP01...